Constance Therapeutics

Constance Therapeutics is a vertically-integrated medicinal therapeutics company producing standardized, science-based whole-plant cannabis extracts. These extracts fill the gap between traditional pharmaceuticals and commonplace cannabis products, providing much needed additional treatment options for physicians and their patients. Constance Therapeutics' extracts are derived from fully trimmed, female, unfertilized cannabis flowers of plants with known genetics using certified organic, pharmaceutical-grade ethanol via a highly-controlled, quantitatively defined and patented process based on solid scientific and engineering principles. Extracts are systematically third-party tested and routinely cross-tested in the industry's most respected laboratories. Since 2008, the company has employed stringent, science-based processes and standards to ensure the highest quality and consistency. Headquartered in San Francisco, CA, Constance Therapeutics' cannabis extracts have historically been available exclusively for therapeutic use by registered California patients under Proposition 215 and California Senate Bill 420. With the new California regulations, in addition to continuing to serve their physician referred medical patients, Constance Therapeutics will distribute their products throughout the state for sale in licensed dispensaries. Additionally, Constance Therapeutics is underway with globally licensing their patented formulations for sale in legal markets across the world.